Media coverage
99
Media coverage
Title Theralink Announces Groundbreaking RPPA Study By Partner GMU - Reveals Novel Therapy Options For Hard-To-Treat Breast Cancer Patients That Could Lead To Significant Improvements In Response Rates Media name/outlet MENAFN -Press Releases (English) Country/Territory Jordan Date 18/12/23 Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet Street Insider Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617596497&p=1gw&v=1&x=dJZ_kgGCX8FECg7fTxPysA Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet InvestorsObserver Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617592643&p=1gw&v=1&x=JgxVgS9kctJwK_yuoxgVRA Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet Yahoo! Finance Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617660143&p=1gw&v=1&x=6ujdvgr7S_4yt41Q6eoIcg Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet Big Country Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617992743&p=1gw&v=1&x=vtEPntO5Enf4J07AnFJcGg Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet Stockwatch Country/Territory Canada Date 18/12/23 URL ct.moreover.com/?a=52617600446&p=1gw&v=1&x=XVMbgUPcOCOCobL6sHMGZA Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU Reveals Novel Therapy Options for Hard to treat Breast Cancer Patients that Could Lead to Significant Improvements Media name/outlet Market News Publishing Country/Territory United States Date 18/12/23 Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet GlobeNewswire Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617598304&p=1gw&v=1&x=ZB0jPKKhdsIcNoGOqFqWFQ Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet Binghamton Homepage Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617731354&p=1gw&v=1&x=X1omDJsw-UHnaC7N1XBYIQ Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet WNTZ Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617745347&p=1gw&v=1&x=aAnph7AF3rDjaxy7w1XcsQ Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet WCBD Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617749570&p=1gw&v=1&x=KvJn1gCkQvPlCLkfsZRcAQ Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet WCIA.com Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617783887&p=1gw&v=1&x=RIbVEJ33XOXbXvSUKpFodg Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet WJBF-TV Country/Territory Georgia Date 18/12/23 URL ct.moreover.com/?a=52617792785&p=1gw&v=1&x=Dp2cCxbeiFc3EHfnp-yLGQ Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet KSNT TV Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617798214&p=1gw&v=1&x=sEIw1QN2CaCF8MJjdIgzXQ Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet Wood TV Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617810571&p=1gw&v=1&x=F_tPmhXM5TGRmgGk04bLUQ Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet WSPA.com Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617812483&p=1gw&v=1&x=vWBxaP7tKjAQWkhX8qRpEQ Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet LocalSRY.com Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617817075&p=1gw&v=1&x=0ymvmLAX8hFXj4OI_6ppaQ Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet Fox8 Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617822763&p=1gw&v=1&x=iu3IYY8kv8M-BhnQ5GqZSw Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet WATE Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617822765&p=1gw&v=1&x=_WDBuUpCd7BTv9eMczuRSA Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet MyStateLine.com Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617830203&p=1gw&v=1&x=GBa2NSio118-9HPfe0vztQ Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet INFORMNNY.com Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617831723&p=1gw&v=1&x=43A2Ok7olIbG9xPVRtlCoA Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet WJET Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617832964&p=1gw&v=1&x=ya7342gvqcb8R7zlvR9SbQ Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet WKRN Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617835611&p=1gw&v=1&x=jZs5hcHZes1h3KGJDOsvVA Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet WKBN 27 First News Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617835881&p=1gw&v=1&x=VqfmVjGkzV5k2a6js9b0bg Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet PIX11 Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617842215&p=1gw&v=1&x=qcF5TqthqJI5t6-L7Hl8XA Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet KOIN Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617848358&p=1gw&v=1&x=5d6lswwwAEenGUY-Jq5vBg Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet Fox 16 Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617850491&p=1gw&v=1&x=lXOK2tkn5ODpd8i3OUbb8A Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet WFXRTV.com Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617853193&p=1gw&v=1&x=jtmbpjId3cR9dQnZqsRkOw Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet WTRF Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617854423&p=1gw&v=1&x=UwSpgHXj6GgTShsxMq8tUQ Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet Rochesterfirst.com Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617854494&p=1gw&v=1&x=IOdVa-a2vRil5qZglNvY9w Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet WDTN Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617865226&p=1gw&v=1&x=yGWx6N1EHR5EdEasu9SUVA Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet WGN-TV Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617868555&p=1gw&v=1&x=Fvjl3iBVAqENlQh_7rpAFQ Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet WKRG Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617868626&p=1gw&v=1&x=2g7hUscV_BYzYuxIYF3ViA Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet KELOLAND TV Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617868632&p=1gw&v=1&x=odafz9zss3kccsAuHosnyQ Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet WETM 18 Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617870759&p=1gw&v=1&x=5zx9FsHftXzg9WSmNIfH5g Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet WJHL.com Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617873391&p=1gw&v=1&x=yrxHIEgPep8yuEDycc8uYQ Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet WHNT-TV Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617880465&p=1gw&v=1&x=bVNDHbZ77t8nOex_QAuPGQ Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet FOX 59 Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617880565&p=1gw&v=1&x=bEdjHmO3TRcK8GkzjJyEsQ Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet KSN Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617880780&p=1gw&v=1&x=FeXwGbFR3uQTqiujBIRxuw Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet KFOR.com Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617880810&p=1gw&v=1&x=cj5vnEgcEM5khk8Kzi49xw Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet WTen.com Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617882713&p=1gw&v=1&x=PI6VWtgwW-FcI--7PYrwxQ Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet WYZZ-TV Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617886694&p=1gw&v=1&x=olsdki60Mdo4k8s_IQlkQg Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet WSAV Country/Territory Georgia Date 18/12/23 URL ct.moreover.com/?a=52617887888&p=1gw&v=1&x=4fG5hiTFLz0zKc5YOZiuHg Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet ABC 4 Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617898357&p=1gw&v=1&x=pYDnahvLvPidrhux8UdA8A Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet WeAreGreenBay.com Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617902495&p=1gw&v=1&x=u2T_E0R3_oDQun5h72q6vA Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet ABC 27 Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617902911&p=1gw&v=1&x=UE5zNytJBM0HyY4GI86pEg Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet MyPanhandle.com Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617910612&p=1gw&v=1&x=YJIfdQvB-aY4Nksh2Qu28g Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet WYTV News Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617913904&p=1gw&v=1&x=SOlT-wazWoxTYBf8KOJLRg Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet My Champlain Valley Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617918523&p=1gw&v=1&x=o37PB4YSUYp5P0B5QaTgxQ Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet WYOU Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617928317&p=1gw&v=1&x=rmzoMMmfA-9Cti9hM4TQ2g Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet KODE TV Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617937057&p=1gw&v=1&x=8DrX9f7oXXSV8RV9TwHKYg Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet KRQE Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617937776&p=1gw&v=1&x=H7aanstesXpII5z7VXgcXQ Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet WIAT TV Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617939172&p=1gw&v=1&x=DuYQr11UnaS8e2oy8f8Hiw Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet WTVW FOX 7 Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617950444&p=1gw&v=1&x=QXvi43rmVAGNg29mJD-hBw Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet KHON 2 Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617958722&p=1gw&v=1&x=LGfpnYDEIOVhyg83P_2PMA Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet WesternSlopeNow.com Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617959303&p=1gw&v=1&x=uW_Wzk6Neenp6D-uICb4BA Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet WBTW News13 Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617960433&p=1gw&v=1&x=oePxecnFWibDMISFULjMRQ Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet Texomashomepage.com Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617965035&p=1gw&v=1&x=33mih-GzXVhFPdcZUexyuA Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet Wavy Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617969729&p=1gw&v=1&x=1UoidlCGdyX_wHh5jIT4EQ Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet WDHN Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617970839&p=1gw&v=1&x=N_s8T1jvkv96-QiEayCMAw Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet CW33 NewsFix Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617972789&p=1gw&v=1&x=LgoydsQRzltL-M31ACR-4w Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet ConchoValleyHomepage.com Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617973083&p=1gw&v=1&x=cBFXN1j0nebtR7_LyjbGEg Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet WVNS Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617976793&p=1gw&v=1&x=ryJUTNi07FlARBXDkrPh2w Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet Siouxland Matters Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617978155&p=1gw&v=1&x=KfLUkFouT-sQFLHBdciTQQ Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet WJTV.com Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617979762&p=1gw&v=1&x=czxEPH66BHAxnOIAYYCbgA Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet NBC4 Columbus Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617984674&p=1gw&v=1&x=B-uA3DHIFYv1TTa2p4IFLA Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet Fox40 KTXL Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617986828&p=1gw&v=1&x=JMX9epeHmw5auwec4IHZ5Q Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet YourCentralValley.com Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617990077&p=1gw&v=1&x=jc7eaLVFyhx9a3REw4ZXGQ Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet Myarklamiss.com Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617991768&p=1gw&v=1&x=fir1hFscpfyqdI2h83uMOg Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet KNWA Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617994733&p=1gw&v=1&x=FdZTEFLmg0PmF2VwNm1CZg Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet CBS17.com Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617996272&p=1gw&v=1&x=1l37bPSojBQiTBvy0PydDw Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet KGET Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52618003402&p=1gw&v=1&x=Xfo4LGF-OUr6ZYJloZK26w Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet WANE-TV Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52618003605&p=1gw&v=1&x=2IfmCnKGMe1fVBgi-gS2Xw Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet KTLA Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52618007577&p=1gw&v=1&x=K2nu2zh43hGWN6KIwpPA8A Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet WLNS Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52618011483&p=1gw&v=1&x=mc-dbKV7BISXOCc-O5LNMg Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet WREG Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52618014079&p=1gw&v=1&x=7uYpAmDr2I09ZGCn_KYWEA Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet CBS4Indy Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52618031958&p=1gw&v=1&x=ijhfSKOC84M9hVe7lN5P6w Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet FOX5 San Diego Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52618035390&p=1gw&v=1&x=ZRFPoRk5k1P_rU4P8re3QA Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet FOX 31 News KDVR Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52618045521&p=1gw&v=1&x=_XkDicVILBoOncMIgoJwig Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet WOWK Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52618066856&p=1gw&v=1&x=Eo7fVNi6Gp_Y64EGcZoBnQ Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet WNCT Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52618075842&p=1gw&v=1&x=SZJJX5Gk4XSxjYX9b3xS0Q Persons Emmanuel Petricoin Title Theralink Technologies, Inc.: Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates Media name/outlet FinanzNachrichten.de Country/Territory Germany Date 18/12/23 URL ct.moreover.com/?a=52617655259&p=1gw&v=1&x=TSRmMUlav25GQgN69834lg Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that Media name/outlet Times of San Diego Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617612511&p=1gw&v=1&x=faNsw6PFEL3VI7vLfkeV0w Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that Media name/outlet L' Observateur Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617613046&p=1gw&v=1&x=jqxACZMIuELFbEVQBYFMNQ Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that Media name/outlet MillisMedway - Local Town Pages Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617613248&p=1gw&v=1&x=qbzTl-EtcC5f1jcfp91smQ Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that Media name/outlet TheTidewaterNews.com Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617614987&p=1gw&v=1&x=vQUQFU9qnDlvKvFF62wRvA Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that Media name/outlet LaGrange Daily News Country/Territory Georgia Date 18/12/23 URL ct.moreover.com/?a=52617616660&p=1gw&v=1&x=uA6UIFU7QgVqUU-pzGxi7w Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that Media name/outlet BluegrassLive.com Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617621432&p=1gw&v=1&x=CxzNerh5_VqzYVRKS3PL2g Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that Media name/outlet Elizabethton.com Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617622859&p=1gw&v=1&x=P9U8KZ3oK1mfuSOa3cTiZA Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that Media name/outlet Holliston - Local Town Pages Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617623929&p=1gw&v=1&x=vp7QZ1wP3jfeJwDpzJrlSg Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that Media name/outlet Suffolk News Herald Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617626213&p=1gw&v=1&x=Yp9NfXu_nL536NBzeKlwkQ Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that Media name/outlet Port Arthur News Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617627852&p=1gw&v=1&x=yJb726BhbxZt5Hg15LLLZw Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that Media name/outlet Jessamine Journal Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617629767&p=1gw&v=1&x=Q11OiJ-AzSsO55BVw3nzqw Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that Media name/outlet Tryon Daily Bulletin Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617639086&p=1gw&v=1&x=MaDYORZgTPYm3H8GWkpNcQ Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that Media name/outlet Luverne Journal Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617642138&p=1gw&v=1&x=oyZDxHohy8JTSc3fW-4lvA Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that Media name/outlet Smithfield Times Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617645451&p=1gw&v=1&x=qSucHOxigG3s6wbkxt22Ug Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that Media name/outlet Winchester Sun Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617653689&p=1gw&v=1&x=hM2o41CuSE0j-0wQ_wLB9Q Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that Media name/outlet Kenbridge Victoria Dispatch Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617659853&p=1gw&v=1&x=a6S7s0fYv3QRkiL5y74Yeg Persons Emmanuel Petricoin Title Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that Media name/outlet Leesville Leader Country/Territory United States Date 18/12/23 URL ct.moreover.com/?a=52617663198&p=1gw&v=1&x=b8h-90li8EZZvwM-Jx3LiA Persons Emmanuel Petricoin